Scrip's Five Must-Know Things - 10 January 2024

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: 2023 drug launch highlights; the M&A outlook for the new year; AstraZeneca’s China cell therapy acquisition; the pre-Christmas deal flow; and India at a turning point for ADCs? https://scrip.citeline.com/SC149606/Quick-Listen-Scrips-Five-MustKnow-Things